Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of CHF 1535 (Foster) in Asthmatic Adolescents
NCT01803087Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Feb 2012
- Primary completion
- Oct 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of beclometasone dipropionate + formoterol in asthma (4 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Area Under the Curve from time 0 to last quantifiable concentration of B17MP. Started Feb 2012; status: completed.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01803087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01803087.